{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=screening&page=6", "query": { "intervention": "screening", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 5791, "total_pages": 580, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=screening&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=screening&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T18:18:25.293Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04557423", "title": "Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Uterine Cervical Neoplasms" ], "interventions": [ { "name": "Community-Based Education", "type": "BEHAVIORAL" }, { "name": "Navigation to Screening", "type": "BEHAVIORAL" }, { "name": "HPV Self-Sampling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Fox Chase Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "30 Years to 65 Years · Female only" }, "enrollment_count": 797, "start_date": "2021-04-08", "completion_date": "2025-11-30", "has_results": false, "last_update_posted_date": "2026-03-24", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04557423" }, { "nct_id": "NCT03503279", "title": "Endotracheal Tube Placement Using McGrath MAC® Video Laryngoscope Versus Macintosh Laryngoscope", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Intubation" ], "interventions": [ { "name": "McGrath MAC® Video Laryngoscope", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2021-01-01", "completion_date": "2021-03-01", "has_results": false, "last_update_posted_date": "2020-06-01", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03503279" }, { "nct_id": "NCT00602160", "title": "Therapeutic Effect of Chinese Herbal Medicine on Food Allergy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Food Allergy" ], "interventions": [ { "name": "FAHF-2 (TM)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Li, Xiu-Min, M.D.", "sponsor_class": "INDIV", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 68, "start_date": "2007-12", "completion_date": "2012-06", "has_results": false, "last_update_posted_date": "2010-11-04", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 2, "location_summary": "Little Rock, Arkansas • New York, New York", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00602160" }, { "nct_id": "NCT03155620", "title": "Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Malignant Solid Neoplasm", "Ann Arbor Stage III Non-Hodgkin Lymphoma", "Ann Arbor Stage IV Non-Hodgkin Lymphoma", "Histiocytic Sarcoma", "Juvenile Xanthogranuloma", "Langerhans Cell Histiocytosis", "Malignant Glioma", "Recurrent Childhood Rhabdomyosarcoma", "Recurrent Ependymoma", "Recurrent Ewing Sarcoma", "Recurrent Glioma", "Recurrent Hepatoblastoma", "Recurrent Langerhans Cell Histiocytosis", "Recurrent Malignant Germ Cell Tumor", "Recurrent Malignant Solid Neoplasm", "Recurrent Medulloblastoma", "Recurrent Neuroblastoma", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Osteosarcoma", "Recurrent Peripheral Primitive Neuroectodermal Tumor", "Recurrent Primary Central Nervous System Neoplasm", "Recurrent Rhabdoid Tumor", "Recurrent Soft Tissue Sarcoma", "Refractory Ewing Sarcoma", "Refractory Glioma", "Refractory Hepatoblastoma", "Refractory Langerhans Cell Histiocytosis", "Refractory Malignant Germ Cell Tumor", "Refractory Malignant Solid Neoplasm", "Refractory Medulloblastoma", "Refractory Neuroblastoma", "Refractory Non-Hodgkin Lymphoma", "Refractory Osteosarcoma", "Refractory Peripheral Primitive Neuroectodermal Tumor", "Refractory Primary Central Nervous System Neoplasm", "Refractory Rhabdoid Tumor", "Refractory Rhabdomyosarcoma", "Rhabdoid Tumor", "Stage III Osteosarcoma AJCC v7", "Stage III Soft Tissue Sarcoma AJCC v7", "Stage IV Osteosarcoma AJCC v7", "Stage IV Soft Tissue Sarcoma AJCC v7", "Stage IVA Osteosarcoma AJCC v7", "Stage IVB Osteosarcoma AJCC v7", "Wilms Tumor" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration and Biopsy", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Ensartinib", "type": "DRUG" }, { "name": "Erdafitinib", "type": "DRUG" }, { "name": "Ivosidenib", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Larotrectinib Sulfate", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Mutation Carrier Screening", "type": "PROCEDURE" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Radionuclide Imaging", "type": "PROCEDURE" }, { "name": "Samotolisib", "type": "DRUG" }, { "name": "Selpercatinib", "type": "DRUG" }, { "name": "Selumetinib Sulfate", "type": "DRUG" }, { "name": "Tazemetostat", "type": "DRUG" }, { "name": "Tipifarnib", "type": "DRUG" }, { "name": "Ulixertinib", "type": "DRUG" }, { "name": "Vemurafenib", "type": "DRUG" }, { "name": "X-Ray Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Months to 21 Years" }, "enrollment_count": 1377, "start_date": "2017-07-31", "completion_date": "2027-01-06", "has_results": true, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 168, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Mesa, Arizona + 126 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03155620" }, { "nct_id": "NCT07753824", "title": "A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Phase II", "Ivonescimab", "Intraperitoneal", "Paclitaxel", "High Grade Metastatic", "Appendiceal Adenocarcinoma" ], "interventions": [ { "name": "Ivonescimab", "type": "DRUG" }, { "name": "IP PTX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2027-01-16", "completion_date": "2032-11-28", "has_results": false, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07753824" }, { "nct_id": "NCT04587258", "title": "Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Colorectal Cancer", "Covid19" ], "interventions": [ { "name": "Informational videos and social media campaigns encouraging cancer screening.", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Rhode Island Hospital", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2020-08-28", "completion_date": "2022-09-01", "has_results": false, "last_update_posted_date": "2020-10-14", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Pawtucket, Rhode Island", "locations": [ { "city": "Pawtucket", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT04587258" }, { "nct_id": "NCT02848989", "title": "Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer Surgery Pain", "Breast Cancer", "Stage 0-III Breast Cancer" ], "interventions": [ { "name": "Qigong Mind-Body Exercise", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 21, "start_date": "2017-04-04", "completion_date": "2023-02-03", "has_results": false, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02848989" }, { "nct_id": "NCT05515224", "title": "5-Cog 2.0: A Pragmatic Clinical Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Cognitive Impairment" ], "interventions": [ { "name": "5-Cog Paradigm (5-Cog battery coupled with clinical decision tool)", "type": "OTHER" }, { "name": "Enhanced usual care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 6600, "start_date": "2023-08-18", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 2, "location_summary": "Bloomington, Indiana • The Bronx, New York", "locations": [ { "city": "Bloomington", "state": "Indiana" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05515224" }, { "nct_id": "NCT03828890", "title": "Assess Screening for Diabetic Retinopathy Using Retinal Camera in Family Medicine Clinic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Screening eye exam using Optos technology", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2019-06-12", "completion_date": "2020-03-15", "has_results": false, "last_update_posted_date": "2020-12-02", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03828890" }, { "nct_id": "NCT00218023", "title": "Medications for Stopping Cocaine Dependence and Preventing Relapse", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cocaine Abuse", "Cocaine-Related Disorders" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Levodopa/Carbidopa", "type": "DRUG" }, { "name": "Naltrexone HCl", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Motivational Interviewing (MI)", "type": "BEHAVIORAL" }, { "name": "Contingency management (CM)", "type": "BEHAVIORAL" }, { "name": "Cognitive-Behavioral Therapy (CBT)", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 101, "start_date": "2006-03", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2017-06-09", "last_synced_at": "2026-10-22T18:18:25.293Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00218023" } ] }